Palo Alto, CA – According to filings with the U.S. Securities and Exchange Commission, Medable is raising $31,099,100.00 in new funding. Sources indicate as part of senior management President and Chief Executive Officer, Michelle Longmire played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Medable

Medable’s mission is to get effective therapies to patients faster. We provide an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO’s to work together as a team in clinical trials. Our solutions enable more efficient clinical research, more effective healthcare delivery, and more accurate precision and predictive medicine. Our vision is to accelerate the path to human discovery and medical cures. We are passionate about driving innovation and empowering consumers. We are proactive, collaborative, self-motivated learners, committed, bold and tenacious. We are dedicated to making this world a healthier place.

To learn more about Medable, visit http://www.medable.com/

Contact:
Michelle Longmire, President and Chief Executive Officer
505-463-8394
michelle@medable.com
https://www.linkedin.com/in/michellelongmire/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved